Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Chr Hansen Holding A/S    CHR   DK0060227585

Delayed Quote. Delayed  - 09/30 04:59:51 pm
394 DKK   +0.51%
09/15 CHR HANSEN A/S : . Hansen to acquire LGG from Valio
09/13 CHR HANSEN A/S : To further strengthen its probiotics offering Chr. ..
08/26 CHR HANSEN A/S : AF wins 5.5 million contract to modernise Chr Hanse..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Chr. Hansen Holding : Announcements from Financière Star 1 S.A. and Novo A/S in accordance with Section 29 of the Danish Securities Trading Act

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/29/2012 | 01:14pm CEST

Hoersholm, 2012-03-29 11:38 CEST (GLOBE NEWSWIRE) --  

Company announcement no.12/2012

Today Chr. Hansen Holding A/S has received major shareholder announcements from Financière Star 1 S.A. and Novo A/S.

According to the announcement from Financière Star 1 S.A., Financière Star 1 S.A. today has sold 35,419,331 shares in Chr. Hansen Holding A/S thus reducing its holdings of shares in Chr. Hansen Holding A/S to 129,442 shares (corresponding to 0.09% of the share capital and voting rights).

According to the announcement from Novo A/S, Novo A/S today has acquired 35,419,331 Chr. Hansen Holding A/S shares and now holds 35,419,331 shares in Chr. Hansen Holding A/S (corresponding to 25.66% of the share capital and voting rights).

The above changes are due to the completion of the share purchase agreement between Financière Star 1 S.A. and Novo A/S announced in company announcement no. 02/2012 of 11 January 2012.

For further information, please contact:

Anders Mohr Christensen, Head of Investor Relations

Tel: +45 4574 7618

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2010/11 financial year was EUR 636 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,300 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.www.chr-hansen.com.

distributed by

This press release was issued by Chr. Hansen Holding A/S and was initially posted at http://investor.chr-hansen.com/releasedetail.cfm?ReleaseID=660271 . It was distributed, unedited and unaltered, by noodls on 2012-03-29 13:06:51 PM. The issuer is solely responsible for the accuracy of the information contained therein.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHR HANSEN HOLDING A/S
09/15 CHR HANSEN A/S : . Hansen to acquire LGG from Valio
09/13 CHR HANSEN A/S : To further strengthen its probiotics offering Chr. Hansen acqui..
08/26 CHR HANSEN A/S : AF wins 5.5 million contract to modernise Chr Hansen plant
07/05 CHR HANSEN A/S : Continued strong growth in Q3
06/30CHR HANSEN HOLDING A/S : quaterly earnings release
06/29 CHR HANSEN A/S : Nola Fit opens the door to lactose-free or sugar reduced yoghur..
04/07 CHR HANSEN A/S : . Hansen adjusts outlook after encouraging Q2 results
03/18 UK sugary drink tax could be sweet for food ingredient suppliers
03/04 CHR HANSEN A/S : . Hansen Holding Enters into Partnership with Caelus Health
01/14 CHR HANSEN A/S : . Hansen to acquire Nutritional Physiology Company and expand i..
More news
Sector news : Food Ingredients
09/30DJMCCORMICK MPANY INCORPORATED : Boosts Full-Year Outlook
09/30DJUNIVERSAL ROBINA : Raises PHP4.38 Billion via Shares Sale
09/30 Nestle Health Science key investments
09/29DJU.S. HOT STOCKS : Hot Stocks to Watch
09/29DJConAgra Revenue Slips as Spinoff Remains On Target
More sector news : Food Ingredients
Advertisement
Financials (€)
Sales 2016 950 M
EBIT 2016 266 M
Net income 2016 183 M
Debt 2016 585 M
Yield 2016 1,32%
P/E ratio 2016 37,50
P/E ratio 2017 32,08
EV / Sales 2016 7,96x
EV / Sales 2017 7,18x
Capitalization 6 973 M
More Financials
Chart CHR HANSEN HOLDING A/S
Duration : Period :
Chr Hansen Holding A/S Technical Analysis Chart | CHR | DK0060227585 | 4-Traders
Full-screen chart
Technical analysis trends CHR HANSEN HOLDIN...
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 55,6 €
Spread / Average Target 5,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Cees de Jong President & Chief Executive Officer
Ole Gjessø Andersen Chairman
Knud Vindfeldt COO, Head-Science, Technology & Supply
Søren Westh Lonning Chief Financial Officer & Executive Vice President
Frédéric P. Stévenin Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CHR HANSEN HOLDING A/S-9.20%7 838
FOSHAN HAITIAN FLAVOUR..-14.06%12 315
KIKKOMAN CORPORATION-22.50%6 683
KEWPIE CORP4.64%4 702
TATE & LYLE PLC25.04%4 536
HAIN CELESTIAL GROUP I..-11.91%3 681
More Results